A Study of JMT101 in Patients With Metastatic Colorectal Cancer

NCT06089330 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer (mCRC)

Interventions

DRUG: JMT101
DRUG: SG001
DRUG: Irinotecan
DRUG: Regorafenib (Stivarga)

Sponsor

Shanghai JMT-Bio Inc.